Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

Phase 2

• Conditions: Sudden Loss of Hearing

• Registration Number: NCT00416143
• Lead Sponsor: Sheba Medical Center

Brief Summary

sudden sensorineural hearing loss:

* idiopathic in most cases

* 5-20/100,000 new cases annually in the U.S

* no establishes pathogenesis

* treated with oral steroids in most cases

* \~50% improvement in hearing levels

* bed rest - acceptable treatment, not well investigated

Detailed Description

Not available

Study Timeline

• Study Start: 2006-06
• Status Verified: 2006-12
• Study First Submitted: 2006-12-24
• Study First Submitted QC: 2006-12-24
• Last Update Submitted: 2006-12-24
• Study First Posted: 2006-12-27
• Last Update Posted: 2006-12-27
• Study Completion: 2008-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• patients with sudden sensorineural hearing loss

Exclusion Criteria

• age less than 16 years
• contraindication for oral steroid treatment
• prior steroid treatment for hearing loss
• pregnent women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
hearing improvement

Trial Locations

Locations (1)

Sheba Medical Center; 🇮🇱 Tel Hashomer, Israel